IndraLab

Statements

USP1 activates cisplatin-resistant non-small cell lung cancer. 2 / 2
| 2
eidos
"Importantly , the USP1 inhibitors act synergistically with the chemotherapy drug cisplatin to inhibit the proliferation of cisplatin-resistant non-small cell lung cancer ( NSCLC ) cells [ 113 ] ."
24239534
eidos
"Importantly , USP1 inhibitors act synergistically with the chemotherapy drug cisplatin to inhibit the proliferation of cisplatin-resistant non-small cell lung cancer ( NSCLC ) cells ( Chen et al. 2011 ; Garcia-Santisteban et al. 2013 ) ."
| PMC